Johnson &amp; Johnson coronavirus vaccine could be in human testing by September , company says  Johnson &amp; Johnson announced Monday it could have a coronavirus vaccine ready for human testing by September .
The company said it has selected a lead vaccine candidate from constructs it 's been working on since January .
The pharmaceutical giant has partnered with the Biomedical Advanced Research and Development Authority , which has committed $1 billion to fund research , development and testing .
Johnson &amp; Johnson said it expects to be able to start human clinical studies of its lead vaccine candidate in September at the latest , and said the first batches of a COVID-19 vaccine could be available for emergency use authorization in early 2021 .
" The world is facing an urgent public health crisis and we are committed to doing our part to make a COVID-19 vaccine available and affordable globally as quickly as possible , " Johnson + Johnson Chairman and CEO Alex Gorsky said in a news release .
The company also said it will establish new vaccine manufacturing capabilities in the U .
and additional production capabilities internationally to @ @ @ @ @ @ @ @ @ @ vaccine is approved .
